To Publications Page     To Home PageSkip to content
NDIC Home  |   What's New  |   Site Map  |   Search US DOJ.gov  |  To DOJ Updated on August 20, 2009

The mission of NDIC is to provide strategic drug-related intelligence, document and computer exploitation support, and training assistance

to the drug control, public health, law enforcement, and intelligence communities of the United States

in order to reduce the adverse effects of drug trafficking, drug abuse, and other drug-related criminal activity.

TTY users please call (814) 532-5815.

New At NDIC

Job Vacancy Announcements

NDIC announces an Information Technology Specialist vacancy. For application details and contact information, refer to the complete vacancy announcement on the NDIC web site.

The U.S. Department of Justice has advertised the Deputy Director position at NDIC. This announcement is open to all sources and is available on USAJOBS at: http://jobview.usajobs.gov/GetJob.aspx?JobID=82461943&q=justice&sort=rv%2c-dtex&jbf565=1&vw=d&re=134&FedEmp=N&FedPub=Y&caller=ses.aspx&AVSDM=2009-07-27+07%3a46%3a00&rc=3&TabNum=7

If you have any questions regarding the Deputy Director announcement, please contact Ms. Kimberly Jackson at (202) 514-4350 or e-mail Kimberly.W.Jackson@usdoj.gov.
 

2009 Drug Market Analyses for the High Intensity Drug Trafficking Areas Now Available

The National Drug Intelligence Center (NDIC) announces the release of 32 High Intensity Drug Trafficking Area (HIDTA) Drug Market Analyses (DMA) for 2009. These reports, produced at the request of the Office of National Drug Control Policy, provide a strategic overview of the illicit drug situation in each of the HIDTA regions. See our What's New page for a listing of the DMAs.  

Methamphetamine Report added

Situation Report: Pseudoephedrine Smurfing Fuels Surge in Large-Scale Methamphetamine Production in California
This Situation Report is in response to a request from the Office of National Drug Control Policy for information regarding pseudoephedrine smurfing in California. The National Drug Intelligence Center collected and analyzed data and reporting from 2007-through May 2009 related to methamphetamine production and pseudoephedrine smurfing. This report draws upon data from the National Seizure System, as well as information obtained through interviews with federal, state, and local law enforcement officers.

Employees of the National Drug Intelligence Center Receive Excellence in Government Awards

June 1, 2009 - In their annual Excellence in Government Awards ceremony, the Pittsburgh Federal Executive Board recognized 22 National Drug Intelligence Center (NDIC) employees for their “deep personal and professional commitment” over the past year.

Multiagency Course August training sites changed

The site locations for the August Multiagency Course training have been changed: Johnston, RI, is cancelled, and the Washington, D.C. area class will be held in Herndon, VA. For further information see our Multiagency Course page. 

NDIC FY08 Accomplishments

The National Drug Intelligence Center (NDIC) has consistently and effectively supported national policymakers and law enforcement decisionmakers by:

  • providing high-quality strategic domestic drug intelligence;

  • facilitating information sharing and liaison between intelligence and law enforcement agencies;

  • providing timely operational support to law enforcement authorities by conducting document and media exploitation of evidence collected during federal, state, and local law enforcement investigations;

  • and providing training in support of the above efforts.

NDIC has been a major contributor to our nation's counternarcotics effort and the U.S. Department of Justice (DOJ) Strategic Plan. A summary of NDIC mission accomplishments during fiscal year (FY) 2008 is now available.  
 

Department of Justice Accomplishments 2001-2009

The Accomplishments of the U.S. Department of Justice 2001-2009 (PDF 1.83 MB) lays out the record of accomplishments and results over the past 8 years. 
 

Featured Publications
DOMEX NEWS

NDIC contributes to sentencing of doctor for illegal prescriptions

NDIC's participation in the investigation of illegal prescriptions aided in the sentencing of a Georgian doctor to serve 10 years in federal prison for his conviction on 175 counts of illegally dispensing prescription drugs from 2002 until his arrest in 2007. Read more in the Doctor Sentenced to 10 Years in Prison for Illegal Prescriptions (pdf) press release.

SENTRY

SENTRY shield linked to SENTRY web site.SENTRY is an Internet-based system designed to collect and disseminate synthetic drug-related data in order to identify new trends at an early stage, evaluate their likely importance, and track their development.

SENTRY focuses on synthetic drugs that are primarily produced via a chemical process, such as LSD (lysergic acid diethylamide), MDMA (3,4-methylenedioxymethamphetamine, also known as ecstasy), and methamphetamine. To be truly effective as an early warning system, however, the system also monitors prescription drugs, over-the-counter medications, botanical substances and extracts, and chemicals and products involved in the manufacturing of synthetic drugs.

Enter the Sentry Web Site

Dynamic Mapping Initiative

Dynamic Mapping Initiative - Select information collected by the National Drug Intelligence Center (NDIC) in the course of producing domestic drug intelligence products is presented on this web site through dynamic and static maps. Interactive maps depicting city and county responses to selected questions from NDIC’s annual National Drug Threat Survey in 2006 and 2007 are currently available.

Addresses

Johnstown:

  319 Washington Street, 5th Floor
  Johnstown, PA 15901-1622
  Telephone: (814) 532-4601
  FAX: (814) 532-4690

 

Washington D.C.:

Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Rm 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040

Freedom of Information Act   |  Accessibility Policy  |  DOJ Privacy Policy  |  Site Map
Send all questions, comments, and suggestions to the NDIC Webmaster.


End of page.